
MetLife, Inc.

MET (MetLife, Inc.) trades at -0.8x EV/Revenue — attractively valued for a financials company with solid margins (36%) and mature growth profile (-4% YoY). The business is approaching profitability at 7% EBIT margins. Forward PE of 7x.
The put/call ratio is a contrarian indicator — extreme fear (>1.2) often marks market bottoms. Extreme greed (<0.7) can signal tops.
MetLife is one of America's largest life insurance companies, providing life insurance, annuities, employee benefits, and retirement solutions to individual and institutional customers. They serve over 90 million customers globally, generating revenue primarily through insurance premiums, investment income, and fees from their asset management business.
MetLife is targeting mid-single digit annual growth driven by expansion in employee benefits and international markets, particularly Asia where they see double-digit growth potential. The company is leveraging digital transformation to reduce costs and improve customer acquisition in a $1.3 trillion global life insurance market.
Operating margins have stabilized around 15-20% following restructuring, with the company generating consistent free cash flow of $4-6 billion annually. MetLife maintains strong capital ratios and has been returning significant capital to shareholders through dividends and share buybacks.
MetLife competes with Prudential Financial, Lincoln National, and Principal Financial in a fragmented market. Their key advantages include scale in employee benefits, strong brand recognition, and global distribution network, though they face increasing competition from InsurTech startups and asset managers entering insurance.
Without recent earnings data available, MetLife's stock performance has generally tracked broader financial sector trends. The company has been executing on its strategic pivot toward higher-margin businesses while maintaining focus on expense management and digital capabilities.
Analyst sentiment on traditional life insurers like MetLife has been cautious given interest rate uncertainty and slow industry growth. The consensus typically focuses on the company's ability to manage through rate cycles and execute on margin expansion initiatives.
MetLife is a defensive play on demographic trends with steady cash flows and dividend income, but investors should expect modest growth in exchange for relative stability in an evolving insurance landscape.
Gold Eagle provides data and AI-generated analysis for informational purposes only. Not investment advice. All data from public sources.








| '25E | '26E | '27E | '28E | |
|---|---|---|---|---|
| Revenue | $83.1B | $79.4B | $83.0B | $87.0B |
| Growth | — | (4%) | +5% | +5% |
| EBITDA | — | $8.2B | $8.5B | $9.0B |
| Growth | — | +5% | +5% | |
| FCF | $18.1B | — | — | — |
| Margin | 22% | — |
MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited
MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend
MetLife, Inc. (MET) Presents at 47th Annual Raymond James Institutional Investor Conference Transcript
MetLife, Unum Group, Wells Fargo, AWS, and Cognizant to Keynote at PegaWorld 2026
AM Best Assigns Issue Credit Rating to MetLife, Inc.'s New Subordinated Debentures
| — |
| — |
| EPS (PF) | $8.69 | $9.78 | $10.93 | $12.30 |
| Growth | — | +13% | +12% | +13% |